Accordian
>
Expertise

Overseas investment

Mayne Wetherell advises on New Zealand’s most complex and strategically significant inbound investments.

Our practice

We act for international investors, private equity sponsors, sovereign funds and corporates on the full range of overseas investment matters from initial structuring and screening through to consent and exemption applications and post-completion compliance.  Our experience covers acquisitions of sensitive land, significant business assets, forestry interests, infrastructure and cross-border joint ventures.

With a deep understanding of the Overseas Investment Office’s evolving processes and policy priorities, we help clients navigate regulatory complexity with clarity and precision.  Drawing on expertise across corporate, finance and tax we deliver advice that aligns regulatory requirements with commercial strategy ensuring transactions progress efficiently and with confidence.

Speak to the team
Working with us

Our services

No items found.
Find a partner
What we've done

Work Highlights

Fortifi Food

Advised Fortifi Food Processing Solutions (Bettcher Industries) on its acquisition by scheme of arrangement of NZX-listed MHM Automation (manufacturing).

Intermediate Capital Group

Advised ICG on the acquisition of Canopy Healthcare, subsequent M&A activities and general corporate matters (healthcare).

John Laing

Advised John Laing on its investment in Northern Express Group (NX2) in connection with the Pūhoi to Warkworth Private Public Partnership with the NZ Government (transport infrastructure).

K9 Natural

Advised KKR on the acquisition of Natural Pet Food (pet food).

Pencarrow

Advised Pencarrow Private Equity on the merger of its portfolio company, PCRN Clinical Trials, with Momentum Clinical Research (healthcare).

Pernod Ricard

Advised Pernod Ricard on the divestment of its New Zealand strategic wine brands to Accolade Wines (beverages).

The Rohatyn Group

Advised The Rohatyn Group on its acquisition of a majority interest in the Matariki Forests estate from Rayonier (forestry).

Recognised for excellence, trusted by clients

Mayne Wetherell's respected corporate team is proficient in advising on capital markets, foreign investments and general commercial matters. The firm is well placed to handle cross-border M&A, with in-depth knowledge of New Zealand's foreign investment regulations. It acts on behalf of a range of corporates, shareholders, institutional investors and private equity houses.

What we do

Related expertise

Debt capital markets

Mayne Wetherell has a market-leading debt capital markets practice, advising New Zealand issuers on their debt-raising transactions.

Learn more
Learn more

Infrastructure

New Zealand’s infrastructure pipeline is expanding and the stakes have never been higher.

Learn more
Learn more

Corporate advisory

Mayne Wetherell’s corporate advisory team is a trusted partner to New Zealand’s leading corporates, investors and boards.

Learn more
Learn more

Private capital

Private capital encompasses the entire capital stack from ordinary equity to debt and in between.  Private capital transactions demand speed, discipline and flawless execution.

Learn more
Learn more

Leveraged finance

Mayne Wetherell partners with sponsors, borrowers and lenders on complex, high-stakes leveraged transactions where layered capital structures and bespoke mechanics are central to the deal.

Learn more
Learn more
Ready for next steps?

Let's talk

Whether you need immediate advice or want to explore how we can support your business, we're here to help.

Find a partner
Get in touch
Latest insights

Keep up to date with us

Stay informed with our latest firm news, legal perspectives and insights on global business change.
See more insights
Celebrating promotions across the Mayne Wetherell team
December 12, 2025
Learn more
Court of Appeal releases its decision in Hoban v Attorney‑General
December 9, 2025
Learn more
Advising Watercare on major financing milestones
December 5, 2025
Learn more
Launching Extraordinary Pay for our team
December 1, 2025
Learn more
Supporting emerging talent in M&A
November 27, 2025
Learn more